These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 16650491

  • 1. Eplerenone offsets cardiac and aortic adverse remodeling in spontaneously hypertensive rats.
    Burla AK, Neves MF, Oigman W, Mandarim-de-Lacerda CA.
    Int J Cardiol; 2007 Jan 02; 114(1):64-70. PubMed ID: 16650491
    [Abstract] [Full Text] [Related]

  • 2. Eplerenone prevents salt-induced vascular remodeling and cardiac fibrosis in stroke-prone spontaneously hypertensive rats.
    Endemann DH, Touyz RM, Iglarz M, Savoia C, Schiffrin EL.
    Hypertension; 2004 Jun 02; 43(6):1252-7. PubMed ID: 15117913
    [Abstract] [Full Text] [Related]

  • 3. Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study.
    Pitt B, Reichek N, Willenbrock R, Zannad F, Phillips RA, Roniker B, Kleiman J, Krause S, Burns D, Williams GH.
    Circulation; 2003 Oct 14; 108(15):1831-8. PubMed ID: 14517164
    [Abstract] [Full Text] [Related]

  • 4. Effects of enalapril, tempol, and eplerenone on salt-induced hypertension in dahl salt-sensitive rats.
    Bayorh MA, Mann G, Walton M, Eatman D.
    Clin Exp Hypertens; 2006 Feb 14; 28(2):121-32. PubMed ID: 16546838
    [Abstract] [Full Text] [Related]

  • 5. Eplerenone potentiates protective effects of amlodipine against cardiovascular injury in salt-sensitive hypertensive rats.
    Nakamura T, Fukuda M, Kataoka K, Nako H, Tokutomi Y, Dong YF, Yamamoto E, Yasuda O, Ogawa H, Kim-Mitsuyama S.
    Hypertens Res; 2011 Jul 14; 34(7):817-24. PubMed ID: 21471977
    [Abstract] [Full Text] [Related]

  • 6. Eplerenone potentiates the antiproteinuric effects of enalapril in experimental nephrotic syndrome.
    Nakhoul F, Khankin E, Yaccob A, Kawachi H, Karram T, Awaad H, Nakhoul N, Hoffman A, Abassi Z.
    Am J Physiol Renal Physiol; 2008 Mar 14; 294(3):F628-37. PubMed ID: 18094029
    [Abstract] [Full Text] [Related]

  • 7. Effects of eplerenone and salt intake on left ventricular remodeling after myocardial infarction in rats.
    Urabe A, Izumi T, Abe Y, Taniguchi I, Mochizuki S.
    Hypertens Res; 2006 Aug 14; 29(8):627-34. PubMed ID: 17137219
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of eplerenone versus enalapril as monotherapy in systemic hypertension.
    Williams GH, Burgess E, Kolloch RE, Ruilope LM, Niegowska J, Kipnes MS, Roniker B, Patrick JL, Krause SL.
    Am J Cardiol; 2004 Apr 15; 93(8):990-6. PubMed ID: 15081441
    [Abstract] [Full Text] [Related]

  • 9. Effect of eplerenone, enalapril and their combination treatment on diabetic nephropathy in type II diabetic rats.
    Kang YS, Ko GJ, Lee MH, Song HK, Han SY, Han KH, Kim HK, Han JY, Cha DR.
    Nephrol Dial Transplant; 2009 Jan 15; 24(1):73-84. PubMed ID: 18682491
    [Abstract] [Full Text] [Related]

  • 10. Changes in the composition of the thoracic aortic wall in spontaneously hypertensive rats treated with losartan or spironolactone.
    Han WQ, Wu LY, Zhou HY, Zhang J, Che ZQ, Wu YJ, Liu JJ, Zhu DL, Gao PJ.
    Clin Exp Pharmacol Physiol; 2009 May 15; 36(5-6):583-8. PubMed ID: 19673944
    [Abstract] [Full Text] [Related]

  • 11. Interactions between aldosterone and connective tissue growth factor in vascular and renal damage in spontaneously hypertensive rats.
    de las Heras N, Ruiz-Ortega M, Miana M, Rupérez M, Sanz-Rosa D, Aragoncillo P, Mezzano S, Cachofeiro V, Egido J, Lahera V.
    J Hypertens; 2007 Mar 15; 25(3):629-38. PubMed ID: 17278980
    [Abstract] [Full Text] [Related]

  • 12. Aldosterone antagonism ameliorates proteinuria and nephrosclerosis independent of glomerular dynamics in L-NAME/SHR model.
    Zhou X, Ono H, Ono Y, Frohlich ED.
    Am J Nephrol; 2004 Mar 15; 24(2):242-9. PubMed ID: 15031627
    [Abstract] [Full Text] [Related]

  • 13. Eplerenone reduces oxidative stress and enhances eNOS in SHR: vascular functional and structural consequences.
    Sanz-Rosa D, Oubiña MP, Cediel E, De las Heras N, Aragoncillo P, Balfagón G, Cachofeiro V, Lahera V.
    Antioxid Redox Signal; 2005 Mar 15; 7(9-10):1294-301. PubMed ID: 16115035
    [Abstract] [Full Text] [Related]

  • 14. Exercise training attenuates cardiovascular adverse remodeling in adult ovariectomized spontaneously hypertensive rats.
    Marques CM, Nascimento FA, Mandarim-de-Lacerda CA, Aguila MB.
    Menopause; 2006 Mar 15; 13(1):87-95. PubMed ID: 16607103
    [Abstract] [Full Text] [Related]

  • 15. Participation of aldosterone in the vascular inflammatory response of spontaneously hypertensive rats: role of the NFkappaB/IkappaB system.
    Sanz-Rosa D, Cediel E, de las Heras N, Miana M, Balfagón G, Lahera V, Cachofeiro V.
    J Hypertens; 2005 Jun 15; 23(6):1167-72. PubMed ID: 15894892
    [Abstract] [Full Text] [Related]

  • 16. Long-term mineralocorticoid receptor blockade reduces fibrosis and improves cardiac performance and coronary hemodynamics in elderly SHR.
    Susic D, Varagic J, Ahn J, Matavelli L, Frohlich ED.
    Am J Physiol Heart Circ Physiol; 2007 Jan 15; 292(1):H175-9. PubMed ID: 16905598
    [Abstract] [Full Text] [Related]

  • 17. Effects of olmesartan and enalapril at low or high doses on cardiac, renal and vascular interstitial matrix in spontaneously hypertensive rats.
    Porteri E, Rodella L, Rizzoni D, Rezzani R, Paiardi S, Sleiman I, De Ciuceis C, Boari GE, Castellano M, Bianchi R, Agabiti-Rosei E.
    Blood Press; 2005 Jan 15; 14(3):184-92. PubMed ID: 16036499
    [Abstract] [Full Text] [Related]

  • 18. Effects of eplerenone on transcriptional factors and mRNA expression related to cardiac remodelling after myocardial infarction.
    Enomoto S, Yoshiyama M, Omura T, Matsumoto R, Kusuyama T, Kim S, Izumi Y, Akioka K, Iwao H, Takeuchi K, Yoshikawa J.
    Heart; 2005 Dec 15; 91(12):1595-600. PubMed ID: 15797934
    [Abstract] [Full Text] [Related]

  • 19. Effects of eplerenone, a selective mineralocorticoid receptor antagonist, on clinical and experimental salt-sensitive hypertension.
    Takeda Y.
    Hypertens Res; 2009 May 15; 32(5):321-4. PubMed ID: 19300447
    [Abstract] [Full Text] [Related]

  • 20. Effect of melatonin, captopril, spironolactone and simvastatin on blood pressure and left ventricular remodelling in spontaneously hypertensive rats.
    Simko F, Pechanova O, Pelouch V, Krajcirovicova K, Mullerova M, Bednarova K, Adamcova M, Paulis L.
    J Hypertens Suppl; 2009 Aug 15; 27(6):S5-10. PubMed ID: 19633453
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.